Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹816Cr
Finance - Holding Company
Rev Gr TTM
Revenue Growth TTM
11.70%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MAXIND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 12.6 | -6.7 | -15.1 | -5.5 | -20.1 | -34.9 | -13.1 | -14.6 | -7.8 | 38.6 | 5.6 | 24.1 |
| 53 | 52 | 54 | 58 | 65 | 54 | 64 | 64 | 81 | 65 | 75 | 78 |
Operating Profit Operating ProfitCr |
| 5.8 | -28.3 | -9.2 | -42.6 | -44.7 | -105.6 | -49.5 | -85.3 | -95.0 | -76.0 | -67.0 | -80.1 |
Other Income Other IncomeCr | 4 | 5 | 6 | 4 | 5 | 6 | 5 | 4 | 4 | 5 | 5 | 7 |
Interest Expense Interest ExpenseCr | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 4 | 3 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 6 | 6 | 6 |
| 1 | -10 | -2 | -17 | -20 | -27 | -22 | -44 | -45 | -25 | -36 | -41 |
| 6 | 2 | 3 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | -2 | 1 |
|
Growth YoY PAT Growth YoY% | -167.9 | -192.8 | -167.1 | -6,292.9 | -416.0 | -120.9 | -383.6 | -149.2 | -113.7 | 4.9 | -49.9 | 3.9 |
| -7.4 | -30.0 | -9.6 | -44.0 | -47.9 | -101.9 | -53.1 | -128.4 | -111.0 | -69.9 | -75.4 | -99.4 |
| -0.8 | -2.7 | -1.0 | -3.9 | -4.7 | -5.9 | -5.0 | -9.5 | -10.1 | -5.4 | -6.5 | -8.2 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -42.7 | 90.2 | -12.6 | -12.6 | -17.2 | 14.4 |
| 216 | 150 | 231 | 201 | 230 | 264 | 299 |
Operating Profit Operating ProfitCr |
| -2.5 | -23.7 | -0.5 | 0.3 | -31.0 | -81.5 | -79.4 |
Other Income Other IncomeCr | 3 | 9 | 8 | 12 | 19 | 19 | 20 |
Interest Expense Interest ExpenseCr | 27 | 24 | 10 | 6 | 5 | 8 | 14 |
Depreciation DepreciationCr | 8 | 10 | 7 | 8 | 10 | 19 | 23 |
| -87 | -64 | -18 | -3 | -49 | -139 | -147 |
| 5 | -11 | -2 | 7 | 7 | 2 | 1 |
|
| | 42.6 | 69.6 | 35.6 | -443.0 | -149.0 | -5.9 |
| -43.9 | -43.9 | -7.0 | -5.2 | -32.1 | -96.5 | -89.3 |
| 55.2 | -9.3 | -3.2 | -2.1 | -12.3 | -29.8 | -30.2 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 54 | 54 | 54 | 43 | 43 | 44 | 52 |
| 652 | 599 | 586 | 495 | 440 | 305 | 415 |
Current Liabilities Current LiabilitiesCr | 162 | 226 | 153 | 161 | 139 | 165 | |
Non Current Liabilities Non Current LiabilitiesCr | 157 | 119 | 64 | 50 | 53 | 109 | |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 819 | 728 | 549 | 459 | 343 | 261 | |
Non Current Assets Non Current AssetsCr | 205 | 270 | 309 | 294 | 341 | 372 | |
Total Assets Total AssetsCr |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -19 | 73 | 67 | 69 | -102 | -128 |
Investing Cash Flow Investing Cash FlowCr | -586 | 13 | 18 | 124 | 159 | 47 |
Financing Cash Flow Financing Cash FlowCr | 557 | -73 | -94 | -119 | -29 | -13 |
|
Free Cash Flow Free Cash FlowCr | -209 | 61 | 64 | 66 | -121 | -152 |
| 20.5 | -136.8 | -412.1 | -668.5 | 181.5 | 90.9 |
CFO To EBITDA CFO To EBITDA% | 359.6 | -253.2 | -5,350.5 | 13,729.3 | 188.1 | 107.7 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 346 | 397 | 352 | 853 | 802 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 2.7 | 1.7 | 1.7 | 4.3 | 4.3 |
Price To Book Price To Book | 0.0 | 0.5 | 0.6 | 0.7 | 1.8 | 2.3 |
| -23.9 | -14.3 | -333.1 | 556.6 | -11.9 | -5.9 |
Profitability Ratios Profitability Ratios |
| 99.5 | 98.8 | 98.0 | 97.8 | 92.5 | 70.3 |
| -2.5 | -23.7 | -0.5 | 0.3 | -31.0 | -81.5 |
| -43.9 | -43.9 | -7.0 | -5.2 | -32.1 | -96.5 |
| -7.1 | -5.3 | -1.1 | 0.6 | -9.2 | -37.3 |
| -13.1 | -8.1 | -2.5 | -1.9 | -11.7 | -40.3 |
| -9.1 | -5.3 | -1.9 | -1.4 | -8.2 | -22.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview and Corporate Structure**
Max India Limited (MIL) is the publicly listed holding company for the senior care and allied businesses within the $5 billion Max Group, one of India’s leading multi-business conglomerates. Following the demerger of non-healthcare assets from Max Healthcare in June 2020, MIL was reconstituted as the dedicated vehicle for the Group’s integrated senior care ecosystem.
The company operates through two primary subsidiaries:
- **Antara Senior Living Limited (ASLL)** – develops and manages independent living communities for seniors.
- **Antara Assisted Care Services Limited (AACSL)** – delivers comprehensive medical and lifestyle care via Care Homes, Care at Home, and AGEasy.
As of March 31, 2025, the Max Group employs approximately 26,000 people, operates ~500 offices across India, and serves ~4 million customers. Its consolidated revenue stood at **₹46,911 crores in FY25**, with core operations spanning life insurance (Max Life), real estate (Max Estates), and senior care under MIL.
---
### **Business Segments and Integrated Ecosystem**
Max India’s strategy revolves around building a fully **integrated senior care ecosystem** that enables cross-selling and enhances customer lifetime value (LTV). The business is structured across two core divisions:
#### 1. **Residences for Seniors**
Antara offers luxury, independent, and assisted living communities designed for individuals aged 55+. Key projects include:
- **Antara Dehradun** (flagship): A 14-acre community offering holistic wellness and lifestyle services. Sold out in Phase 1; remains cash surplus and profitable.
- **Antara Noida** (Sector 150): A 340-apartment project developed in partnership with Contend Builders. Phase I is ready for possession. Fully sold out.
- **Estate 360, Gurugram**: A 292-unit senior living component of Max Estates’ intergenerational project. Fully sold and operational.
- **Future Developments**: Land parcels identified in **Gurugram (Phase II), Bangalore, Hyderabad, Chandigarh, Pune, and Goa**. Target of **8–10 integrated communities over the next 5–6 years**.
The model blends healthcare, hospitality, insurance, and wellness into a "Lifestyle with Lifecare" proposition, focusing on physical, emotional, social, intellectual, and spiritual well-being.
#### 2. **Assisted Care Services**
Operated under Antara Assisted Care Services Limited, this vertical provides medical and supportive care for seniors with chronic or age-related conditions, through four key services:
##### a. **Care Homes**
- Operates **6 facilities across Gurugram, Noida, Bengaluru, and Chennai**, with **~490 beds in total** (340 operational, ~150 nearing launch).
- Full capacity target of **~500 beds by Q3 FY26**, rising to **2,000 beds over five years**.
- Services include long-term medical supervision, short-term recuperative care, and recuperation post-surgeries or illness.
- The Gurugram facility is **NABH-accredited**, with a specialization in **Memory Care for dementia and Parkinson’s patients**—India’s only such home.
- Contribution margins have turned positive in multiple cities (Chennai: 5%, Bengaluru: 6%) due to improved occupancy and optimized operations.
- Occupancy continues to ramp up: **Gurugram peaked at 68% in late 2023**, with break-even achieved at just 45% (better than planned 60%). Newer locations (e.g., Sector 24 Gurugram) at 20–25%, with strong growth trajectory expected.
##### b. **Care at Home**
- Trained medical professionals deliver in-home care across **Delhi-NCR, Bengaluru, and Chennai**.
- Generated **₹5.24 crores in net revenue in Q2 FY26**, a **21% YoY growth**.
- Segment Q2 revenue in FY26 stood at **₹9.16 crores**, up 1.2x QoQ and 1.5x YoY in H1.
- Q1 FY26 achieved record **₹4.94 crores in revenue**, with 24% YoY growth.
- Bengaluru and Chennai markets showed **110% YoY revenue growth**, driven by high-margin offerings (critical care, physiotherapy).
- Serves **3,400 patients in Q2 FY26**, with **37,000+ patients served cumulatively**.
- Strategic focus remains on **higher-margin services, geographic expansion, and scaling clinical capabilities**.
##### c. **AGEasy**
- Phyigital (physical + digital) direct-to-consumer platform offering senior-specific **non-prescription health products** to manage chronic conditions.
- Focus areas: **Fall management (walkers, braces), Lung care (nebulizers, oximeters), and Joint pain (supports, bunion correctors)**.
- Serves over **500,000 customers** (including 50,000 repeat), with **INR 20.9 crores in net revenue in Q2 FY26**.
- Operates at a **monthly run rate of ₹7–8 crores**, up 1.5x QoQ.
- H1 revenue in FY26: **INR 35 crores**, 3.3x YoY growth.
- Distributes through **600+ retail and pharmacy outlets and 60 distributor partners across North India**, with South India expansion underway.
- Key partnerships:
- **Axle Bank** – leveraging 3 million Silver Linings customers for distribution; initial sales: 200,000 units.
- **Boat** – co-developing senior-friendly electronics.
- **Wellbeing Nutrition** – co-developing nutraceuticals for seniors (Vitamin D/B12 supplements).
- Revenue model now fully aligned with **private-label Antara-branded products** (phased out third-party SKUs), improving margins.
- Website redesigned for mobile-first experience. Platform GDPR/HIPAA-compliant with AWS cloud infrastructure.
##### d. **MedCare**
(Now fully integrated into AGEasy)
- Formerly offered rental and retail of medical equipment (walkers, wheelchairs, nebulizers).
- Played a pivotal role in early growth; now embedded within AGEasy as part of the product and service stack.
---
### **Financial Highlights (FY25–FY26)**
- **Care Homes**:
- Q2 FY26 revenue: **₹3.91 crores** (+1.3x QoQ), H1 FY26: **₹6.84 crores** (~2.1x YoY).
- FY25 revenue: **₹7.6 crores** (+38% YoY).
- **Care at Home**:
- Q2 FY26: **₹5.24 crores** (+21% YoY), H1 FY26: part of **₹17.02 crores total Assisted Care Services revenue**.
- Q4 FY25: record **₹4.6 crores**, +52% YoY.
- **AGEasy**:
- Q1 FY26: **₹14.2 crores** (2.2x YoY growth).
- Annualized run rate: **₹70–75 crores** (as of Aug 2025).
- **Assisted Care Services (Aggregate)**:
- Q2 FY26: **₹9.16 crores**, up 1.2x QoQ.
- H1 FY26: **₹17.02 crores**, +1.5x YoY.
- FY25: **₹65.2 crores in net revenue**, with a **run rate exceeding ₹100 crores** as of Mar 2025.
- **Operational Margins**:
- Overall business margin improved to **14% in Q4 FY25** (from 9% YoY), driven by service mix optimization and improved capacity utilization.
- Care at Home NCR contribution margin: up from 19% to **25%**.
---
### **Strategic Initiatives and Growth Drivers**
1. **Technology Integration**
- Implemented **ERP systems** and **mobile apps** for real-time monitoring and geo-fenced care tracking.
- **MyAdda visitor management system** enhances resident security.
- Integrated Property Management, POS, and Club Management systems ensure operational standardization.
2. **Geographic Expansion**
- Entered **South India in FY24**, launching Care at Home and AGEasy in **Bangalore and Chennai**.
- Aggressively expanding in **Hyderabad, Chandigarh, and Pune**; term sheets signed for major projects.
3. **Capital and Monetization Strategy**
- Raised **₹43 crores for AGEasy** in FY24; plans new capital raise in 1–2 tranches over 12–18 months.
- Pursuing **asset-light strategy** (Antara 2.0) through development management agreements (e.g., Noida, Estate 360).
- Monetization of non-core land in Greater Noida underway.
4. **Marketing and Customer Acquisition**
- Shifted to **digital-first marketing**: SEO, social media, WhatsApp, and email.
- **Conversion rates improved** via hospital partnerships, doctor referrals, and webinars.
- High **Net Promoter Scores (NPS)** and **resident referrals** (over 50% in Dehradun) driving organic growth.